hey @comincon what are your thoughts on the psychedelics business producing a recurring revenue stream? We know our CBD drugs will continue to have customers coming back as the medication requires to be taken regularly in order to continue receiving the health benefits.
My main concern with psychedelics is purely the long term profitability. I have no doubt there are some amazing health benefits but I do question whether we'll have those repeat users like we do with our CBD candidates. I assume the BOD will want to create something similar with our psychedelics arm where regular sessions are required to experience the full benefit rather than coming in for a couple of doses and then no longer requiring the medicine.
- Forums
- ASX - By Stock
- IHL
- Industry news
Industry news, page-422
-
- There are more pages in this discussion • 477 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online